What is Combi-Blocks?
Combi-Blocks operates as a global supplier of laboratory reagents, focusing on a diverse array of chemical compounds. Their specialized offerings include boronic acids, imidazoles, and amino acids, which serve as critical building blocks for researchers and laboratories worldwide. The company facilitates access to these essential scientific materials through an efficient online ordering system and other distribution channels, catering to a broad international clientele across regions such as Brazil, China, Europe, India, Japan, and Korea.
How much funding has Combi-Blocks raised?
Combi-Blocks has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Combi-Blocks
PPP
Public-Private Partnership
What's next for Combi-Blocks?
The substantial capital infusion, particularly the recent strategic investment, positions Combi-Blocks for significant expansion and further development within the life sciences and chemical research sectors. This backing is expected to fuel advancements in their product lines, enhance global distribution networks, and potentially support research and development initiatives. As a late-stage company, Combi-Blocks is likely to leverage this financing to solidify its market leadership, explore new chemical compound innovations, and strengthen its partnerships with research institutions and distributors globally.
See full Combi-Blocks company page
